Dr. Cavaliere is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1301 Palm Ave
Jacksonville, FL 32207Phone+1 904-202-7300Fax+1 904-202-2754
Education & Training
- University of Virginia Medical CenterFellowship, Neuro-Oncology, 2003 - 2005
- University of Virginia Medical CenterResidency, Neurology, 2000 - 2003
- Westchester Medical CenterInternship, Internal Medicine, 1999 - 2000
- New York Medical CollegeClass of 1999
Certifications & Licensure
- FL State Medical License 2015 - 2026
- OH State Medical License 2005 - 2017
- VA State Medical License 2000 - 2006
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Sunitinib in Treating Patients With Recurrent Malignant Gliomas Start of enrollment: 2007 Jun 01
- Phase I Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Start of enrollment: 2012 Nov 09
- LUMINOS-101: Lerapolturev (PVSRIPO) and Pembrolizumab in Patients With Recurrent Glioblastoma Start of enrollment: 2020 Oct 21
- Join now to see all
Publications & Presentations
PubMed
- 102 citationsLow-grade gliomas: an update on pathology and therapyRobert Cavaliere, Maria Beatriz Lopes, David Schiff
The Lancet. Neurology. 2005-11-01 - 121 citationsPhase II multicenter study of gene-mediated cytotoxic immunotherapy as adjuvant to surgical resection for newly diagnosed malignant glioma.Lee A. Wheeler, Andrea G. Manzanera, Susan Bell, Robert Cavaliere, John M. McGregor
Neuro-Oncology. 2015-11-01 - 108 citationsPhase IB Study of Gene-Mediated Cytotoxic Immunotherapy Adjuvant to Up-Front Surgery and Intensive Timing Radiation for Malignant GliomaE. Antonio Chiocca, Laura K. Aguilar, Susan Bell, Balveen Kaur, Jayson Hardcastle
Journal of Clinical Oncology. 2011-09-20
Press Mentions
- Mason Health Welcomes New Specialty Providers: Danielle Blood, MD, Robert Cavaliere, DPM, and Ross Vogelgesang, MDOctober 5th, 2021
- The Players Tees up Big Surprise for Young Cancer PatientsMarch 10th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: